Page 14 - Isk Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Latest: S. Korea not ruling out curbing vaccine exports The Associated Press FacebookTwitterEmail 3 1of3People wearing face masks pass by a banner displaying precautions against the coronavirus on a street in Seoul, South Korea, Monday, April 5, 2021. The banner reads " We can overcome Corona 19."Ahn Young-joon/APShow MoreShow Less 2of3A person with a protective mask to help curb the spread of the coronavirus wears samurai wig Tuesday, April 6, 2021, in Tokyo. The Japanese capital confirmed more than 390 new coronavirus cases on Tuesday.Eugene Hoshiko/APShow MoreShow Less 3of3...

Credit loans surge more than 3.5 trillion won in just 2 days

SK Bioscience draws record deposits in 2-day public subscription

NH Investment likely to be top beneficiary from SK Bioscience IPO Posted : 2021-02-18 16:01 Updated : 2021-02-18 17:05 NH Investment & Securities CEO Chung Young-chae, left, and NongHyup Financial Group CEo Son Byung-hwan / Courtesy of NongHyup Financial Group NH Investment expected to earn 5.5 billion won for IPO underwriter fee By Anna J. Park With vaccine manufacturer SK Bioscience's initial public offering (IPO) scheduled for next month, NH Investment & Securities is set to become the largest beneficiary of the public offering fee. Given that the contract manufacturing organization (CM...

SK Bioscience to license in Novavax' COVID-19 vaccine